MDRI Clinical Trials


Summer News from MDRI

SUMMER GREETINGS! We thought we’d reach out to you to wish you an enjoyable summer! Here are some updates regarding some of the skin conditions we help treat: Psoriasis Risankizumab (an IL-23 inhibitor) has received FDA approval for the treatment of moderate-to-severe plaque psoriasis. We are proud to have been […]

sticky-note-Summer

Psoriasis Clinical Trial – NOW ENROLLING

Do you know anyone suffering from psoriasis? Call Today – 855.554.6374 note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel. Clinical Trial Government Identifier #NCT03624127 Sponsor: Bristol-Myers Squibb Genders eligible for study: Male/Female Ages eligible for study: 18 and older NEW STUDY – NOW […]


New Year, New Clinical Trial, NOW ENROLLING

Do you know anyone suffering from psoriasis? Call Today – 855.554.6374 note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel. Clinical Trial Government Identifier #NCT03384745 Sponsor: Bond Avillion Development Genders eligible for study: Male/Female Ages eligible for study: 18 – 75 years NEW STUDY […]


Psoriasis Arms

Suffering from Psoriasis? New Clinical Trial

NOW ENROLLING – NEW Psoriasis Clinical Trial Do you know anyone suffering from psoriasis? Call Today – 855.554.6374 Clinical Trial Government Identifier #NCT03635099 Sponsor: Boehringer Ingelheim Genders eligible for study: Male/Female Ages eligible for study: 18 years and older NEW STUDY – Moderate to Severe plaque psoriasis present for at least 6 […]